214 related articles for article (PubMed ID: 34973118)
21. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Sako M; Saito-Oba M; Nozu K; Shima Y; Iijima K; Yoshikawa N;
BMC Nephrol; 2018 Sep; 19(1):223. PubMed ID: 30200895
[TBL] [Abstract][Full Text] [Related]
22. HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome.
Gbadegesin RA; Adeyemo A; Webb NJ; Greenbaum LA; Abeyagunawardena A; Thalgahagoda S; Kale A; Gipson D; Srivastava T; Lin JJ; Chand D; Hunley TE; Brophy PD; Bagga A; Sinha A; Rheault MN; Ghali J; Nicholls K; Abraham E; Janjua HS; Omoloja A; Barletta GM; Cai Y; Milford DD; O'Brien C; Awan A; Belostotsky V; Smoyer WE; Homstad A; Hall G; Wu G; Nagaraj S; Wigfall D; Foreman J; Winn MP;
J Am Soc Nephrol; 2015 Jul; 26(7):1701-10. PubMed ID: 25349203
[TBL] [Abstract][Full Text] [Related]
23. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
[TBL] [Abstract][Full Text] [Related]
24. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.
Ito S; Kamei K; Ogura M; Udagawa T; Fujinaga S; Saito M; Sako M; Iijima K
Pediatr Nephrol; 2013 Feb; 28(2):257-64. PubMed ID: 23052656
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
Sharma S; Kalra S; Shukla S; Sharma P
Nephrology (Carlton); 2022 Sep; 27(9):758-762. PubMed ID: 35619554
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial.
Hogan J; Perez A; Sellier-Leclerc AL; Vrillon I; Broux F; Nobili F; Harambat J; Bessenay L; Audard V; Faudeux C; Morin D; Pietrement C; Tellier S; Djeddi D; Eckart P; Lahoche A; Roussey-Kesler G; Ulinski T; Boyer O; Plaisier E; Cloarec S; Jolivot A; Guigonis V; Guilmin-Crepon S; Baudouin V; Dossier C; Deschênes G
BMJ Open; 2020 Sep; 10(9):e037306. PubMed ID: 32967877
[TBL] [Abstract][Full Text] [Related]
27. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
Singh DN; Krishnamurthy S; Kamalanathan SK; Harichandrakumar KT; Sivamurukan P
Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
[TBL] [Abstract][Full Text] [Related]
28. Correlation between Toll-like Receptor Gene Polymorphisms and Idiopathic Nephrotic Syndrome in Chinese Children.
Gao HH; Li W; Shou XY; Mao JH
Curr Med Sci; 2023 Jun; 43(3):585-591. PubMed ID: 37115397
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypic Alterations in Adult Patients with Steroid-Dependent and Frequently Relapsing Nephrotic Syndrome.
Casiraghi F; Todeschini M; Podestà MA; Mister M; Ruggiero B; Trillini M; Carrara C; Diadei O; Villa A; Benigni A; Remuzzi G
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175393
[TBL] [Abstract][Full Text] [Related]
30. Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome.
Inoki Y; Kamei K; Nishi K; Sato M; Ogura M; Ishiguro A
Pediatr Nephrol; 2022 May; 37(5):1057-1066. PubMed ID: 34606002
[TBL] [Abstract][Full Text] [Related]
31. Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria.
Vallés P; Peralta M; Carrizo L; Martin L; Principi I; Gonzalez A; Manucha W
Pediatr Nephrol; 2000 Dec; 15(3-4):252-8. PubMed ID: 11149121
[TBL] [Abstract][Full Text] [Related]
32. [Incidence of hypogammaglobulinaemia in children with steroid-dependent/frequently relapsing nephrotic syndrome treated with rituximab and its association with severe infections].
Zhi YZ; Cao L; Ying DJ; Dou WJ; Gu R; Zhang JJ
Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(6):433-439. PubMed ID: 38326055
[No Abstract] [Full Text] [Related]
33. Rituximab for nephrotic syndrome in children.
Iijima K; Sako M; Nozu K
Clin Exp Nephrol; 2017 Apr; 21(2):193-202. PubMed ID: 27422620
[TBL] [Abstract][Full Text] [Related]
34. Early Rituximab as an Add-On Therapy in Children With the Initial Episode of Nephrotic Syndrome.
Liu J; Deng F; Wang X; Liu C; Sun S; Zhang R; Zhang A; Jiang X; Yan W; Dou Y; Zhang Y; Xie L; Qian B; Shen Q; Xu H
Kidney Int Rep; 2024 May; 9(5):1220-1227. PubMed ID: 38707815
[TBL] [Abstract][Full Text] [Related]
35. Association of DQB1*0302 alloantigens in Japanese pediatric patients with steroid-sensitive nephrotic syndrome.
Abe KK; Michinaga I; Hiratsuka T; Ogahara S; Naito S; Arakawa K; Tsuru N; Tokieda K
Nephron; 1995; 70(1):28-34. PubMed ID: 7617114
[TBL] [Abstract][Full Text] [Related]
36. Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology.
George J; Alex S; Thomas ETA; Gracious N; Vineetha NS; Kumar S
Kidney360; 2020 May; 1(5):359-367. PubMed ID: 35369364
[TBL] [Abstract][Full Text] [Related]
37. Predictors of poor outcome in children with steroid sensitive nephrotic syndrome.
Mishra K; Kanwal SK; Sajjan SV; Bhaskar V; Rath B
Nefrologia (Engl Ed); 2018; 38(4):420-424. PubMed ID: 29429831
[TBL] [Abstract][Full Text] [Related]
38. Population Pharmacokinetics of Rituximab in Pediatric Patients With Frequent-Relapsing or Steroid-Dependent Nephrotic Syndrome.
Chen Y; Shen Q; Dong M; Xiong Y; Xu H; Li Z
Front Pharmacol; 2021; 12():725665. PubMed ID: 34539407
[No Abstract] [Full Text] [Related]
39. HLA-DR, -DQB typing of steroid-sensitive idiopathic nephrotic syndrome children in Taiwan.
Huang YY; Lin FJ; Fu LS; Lan JL
Nephron Clin Pract; 2009; 112(2):c57-64. PubMed ID: 19390203
[TBL] [Abstract][Full Text] [Related]
40. Hearing status in children with frequently relapsing and steroid resistant nephrotic syndrome.
Saha A; Gupta V; Kapoor K; Dubey NK; Lal P; Sidhu TS; Batra VV; Upadhyay AD
Pediatr Nephrol; 2013 Mar; 28(3):439-45. PubMed ID: 23233039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
